Medicines 17 Flashcards
What is Cauda equina syndrome and what are the symptoms?
Cauda equina syndrome (CES) is a medical emergency that occurs when the nerves at the bottom of the spinal cord are compressed. This compression can be caused by a herniated disk, tumor, infection, or trauma.
Symptoms
Back pain
Weakness in the legs
Numbness in the legs
Bladder dysfunction
Bowel dysfunction
Sexual dysfunction
Loss of sensation in the genitals
Loss of sensation when urinating or defecating
For children using a steroid inhaler or nasal spray what annual monitoring should be done?
The height and weight of children receiving prolonged treatment with inhaled corticosteroids should be
monitored annually.
What is the guidance for treating anaphylaxis in the community (ages aswell)
By intramuscular injection
CHILD UP TO 6 MONTHS 100–150 micrograms (0.1–0.15 mL), repeated after 5 minutes if necessary
CHILD 6 MONTHS–5 YEARS 150 micrograms (0.15 mL), repeated after 5 minutes if necessary
CHILD 6–11 YEARS 300 micrograms (0.3 mL), repeated after 5 minutes if necessary
CHILD 12–17 YEARS 500 micrograms (0.5 mL), repeated after 5 minutes if necessary; 300 micrograms (0.3 mL) should be given if child is small or prepubertal
ADULT 500 micrograms (0.5 mL), repeated after 5 minutes if necessary
If life-threatening features persist, further doses of intramuscular adrenaline/epinephrine can be given every 5 minutes until specialist critical care available.
High-flow oxygen should be given as soon as available.
What is the guidance regarding a diabetic hypo in practice?
Hypoglycaemia Management – Revision Notes
Child ≤5 Years
By Mouth: 5 g glucose
Options:
20 mL Lift®
1.5 glucose tablets
½ tube glucose 40% gel
1 tsp sugar in water
Repeat after 15 min if needed.
By Buccal: 5 g (½ tube glucose 40% gel), repeat after 15 min if needed.
Child 5–11 Years
By Mouth: 10 g glucose
Options:
40 mL Lift®
3 glucose tablets
1 tube glucose 40% gel
2 tsp sugar in water
Repeat after 15 min if needed.
By Buccal: 10 g (1 tube glucose 40% gel), repeat after 15 min if needed.
Child 12–17 Years
By Mouth: 15 g glucose
Options:
60 mL Lift®
4 glucose tablets
1.5 tubes glucose 40% gel
3 tsp sugar in water
Repeat after 15 min if needed.
By Buccal: 15 g (1.5 tubes glucose 40% gel), repeat after 15 min if needed.
Adult
By Mouth: 15–20 g glucose
Options:
60–80 mL Lift®
4–5 glucose tablets
1.5–2 tubes glucose 40% gel
150–200 mL pure fruit juice
3–4 tsp sugar in water
Repeat after 15 min if needed.
By Buccal: 15–20 g (1.5–2 tubes glucose 40% gel), repeat after 15 min if needed.
Unresponsive or Oral Route Not Possible
Glucagon Injection (GlucaGen®)
IM Injection:
Child ≤8 years or ≤25 kg: 500 micrograms (0.5 mL)
Child ≥9 years or >25 kg: 1 mg (1 mL)
Adult: 1 mg (1 mL)
If no response after 10 min, proceed to IV glucose.
IV Glucose Infusion
10% Glucose (500 mg/kg)
Child: 5 mL/kg
Adult: 150–200 mL over 15 min
20% Glucose
Adult: 75–100 mL over 15 min
When does a missed dose of the pill no longer provide effective protection?
A missed pill is one that is 24 or more hours late. If a woman misses only one pill, she should take an active pill as
soon as she remembers and then resume normal pill-taking. No additional precautions are necessary.
What are the rules regarding distruction of controlled drugs tablets and aerosols?
Aerosol formulations should be expelled into water and the resulting liquid disposed of in an appropriately-
sized CD denaturing kit.
It is advisable to grind or crush solid dose formulations before adding them to a CD denaturing kit to ensure
that whole tablets or capsules are not retrievable.
What key prescribing infromation is there with glyceryl trinitrate tablets?
Glyceryl trinitrate tablets are available in strengths of 500- and 600-micrograms—tablets should be supplied in glass containers of not more than 100 tablets, closed with a foil-lined cap, and containing no cotton wool wadding; they should be discarded after 8 weeks in use.
Which beta blockers are more likely to cause nightmares and why?
Water soluble – atenolol, sotalol, nadolol – less likely to enter the brain, therefore less likely to cause sleep
disturbance and nightmares
Lipid soluble – labetalol, oxprenolol, propranolol, timolol - MORE LIKELY TO CAUSE NIGHTMARES
What can spironolactone and furosemide cause if taken together?
(Hyponatraemia) - Both spironolactone and furosemide reduce sodium and this can be potentiated together
What happens if fluconazole and domperidone are taken together?
(QT interval prolongation) – Domperidone increases the risk of QT-prolongation when given with fluconazole.
Manufacturer advises avoid
What does a black triangle next to a medication mean?
The medicine has a black triangle meaning limited
experience with the medication. In this case, all ADRs should be reported
What are the symtoms of hyponatraemia?
Mild (Na+ 130–135 mmol/L):
Nausea
Fatigue
Headache
Moderate (Na+ 125–129 mmol/L):
Confusion
Dizziness
Vomiting
Muscle weakness
Severe (Na+ <125 mmol/L):
Altered mental status
Seizures
Coma
Respiratory distress
Onset:
Acute: Rapid symptoms (seizures, coma).
Chronic: Milder symptoms (fatigue, cognitive impairment).
How would you advise someone with measles?
Measles a virus so no antibiotics
Ask for an urgent GP appointment
What is 1st and 2nd line treatment for meningitis according to BNF treatment summaries section?
1st line: Benzylpenicillin sodium injection (600 mg, 1.2 g) or Ceftriaxone injection (250 mg, 1 g, 2 g).
2nd line Chloramphenicol
Benzylpenicillin sodium injection (600 mg, 1.2 g)
By intravenous injection (or by intramuscular injection if venous access not available)
CHILD 1 MONTH–11 MONTHS 300 mg
CHILD 1–9 YEARS 600 mg
CHILD 10–17 YEARS 1.2 g
ADULT 1.2 g
or
Ceftriaxone injection (250 mg, 1 g, 2 g)
By deep intramuscular injection
CHILD 1 MONTH 250 mg
CHILD 2–11 MONTHS 500 mg
CHILD 1–4 YEARS 1 g
CHILD 5–8 YEARS 1.5 g
CHILD 9–11 YEARS 2 g
By intravenous injection or by deep intramuscular injection
CHILD 12–17 YEARS 2 g
ADULT 2 g
What is the lipid target following a stroke?
evidence of atherosclerosis should aim to reduce fasting LDL-cholesterol below 1.8 mmol/L (equivalent to a non-HDL-cholesterol below 2.5 mmol/L in a non-fasting sample)